Paediatric HIV Stakeholders’ Meeting

3-4 October 2018 
Kampala, Uganda

The 2018 Paediatric HIV Stakeholder’s Meeting brings together key partners of DNDi to discuss vital issues concerning access to ART adapted to the needs of infants and young children living with HIV, their families, and their caregivers.



Date: Wednesday, 3 October 2018
Time: 09:00-09:20
Venue: Speke Resort, Munyonyo, Kampala, Uganda

Opening speech and meeting objectives

François Bompart, Director of Paediatric HIV/HCV Programmes, DNDi, Switzerland

Sara Padidar, Programme Officer, Unitaid


Panel discussions

New treatments for children living with HIV: DNDi’s journey so far

Time: 09:20-10:30

Chair: François Bompart, Director of Paediatric HIV/HCV Programmes, DNDi, Switzerland

Update on DNDi’s paediatric HIV programme
Isabelle Andrieux-Meyer, Head of Clinical Development Paediatric HIV/HCV Programmes, DNDi, Switzerland

Pharmaceutical development of LPV/r-based formulations to meet the needs of infants and children: what lessons have we learned?
Jean-René Kiechel, Expert in R&D (FACT & HIV), DNDi, Switzerland


Front-line experience from clinical study and programmatic implementation

Time: 11:00-12:30

Chairs: Adeodata Kekitiinwa, Executive Director, Baylor College, Uganda & Mastidia Rutaihwa, National AIDS Control Program, Ministry of Health, Tanzania

LIVING study experience from the investigators: what have we learned in Kenya, Uganda and Tanzania
Caren Mburu, Kenyatta Hospital, Kenya
Kathy Kyakwera, MSF/Epicentre, Uganda
Nzovu Ulenga, Director, Health  Systems  Strengthening  and  Strategic  Information, Management and Development for Health (MDH), Tanzania

Uptake of LPV/r-based formulations (syrup and pellets) in children: experience from Kenya and Uganda
Laura Oyiengo, Pediatric and Adolescent HIV Program Manager, Ministry of Health, Kenya & Cordelia Katureebe, Head of Delegation, Ministry of Health, Uganda


Looking forward – Access

Time: 13:30-15:10

Chair: Olawale Salami, Paediatric HIV Clinical Project Manager, DNDi Africa, Kenya

An update on the pharmacokinetic and safety study of the 4-in-1 formulation
Victor Musiime, Senior Lecturer at Makerere University, College of Health Sciences, Department of Paediatrics and Child Health, Uganda

New WHO treatment guidelines for children living with HIV and implications for programme implementation
Elizabeth Obimbo, Department of Paediatrics & Child Health, School of Medicine, University of Nairobi & Consultant Pediatrician, Kenyatta National Hospital, Kenya
The role of civil society in spearheading advocacy for better treatment options in children living with HIV
Proscovia Namakula, Global Coalition of Women Against AIDS, Uganda


Open discussion

What are the key considerations in ensuring access to child-adapted ARV formulations in 2019 and beyond?

Time: 15:30-16:00

Chair: Olawale Salami, Paediatric HIV Clinical Project Manager, DNDi Africa, Kenya



More information: